RecruitingNot ApplicableNCT06268184

Effect of Omega 3 on Oxidative Stress and Nutritional Status of Children on Regular Dialysis

Effect of Omega 3 Supplementation on Nutritional Status and Oxidative Stress in Children and Adolescents With End Stage Renal Disease on Regular Hemodialysis


Sponsor

Tanta University

Enrollment

45 participants

Start Date

Oct 4, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

evaluaion the effects of oral omega-3 supplementation on nutritional status and oxidative stress in pediatric patients with end stage renal disease on regular hemodialysis


Eligibility

Min Age: 6 YearsMax Age: 18 Years

Inclusion Criteria2

  • ESRD children and adolescents on regular hemodialysis for at least 3 months
  • Age ranging from 6 to18 years.

Exclusion Criteria4

  • Systematic disease other than CKD eg SLE
  • Severe active infection.
  • Allergies to any of the ingredients in omega-3 product used in this study (e.g. fish oil, bovine gelatin).
  • Omega-3 fatty acid or any other antioxidants consumption within the last 6 months.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTD3 LAB SYRUP

omega 3 suplementation

DIETARY_SUPPLEMENTplacebo syrup

placebo syrup contains purified water, glycerin, xanthan gum, tween 80, methyl paraben, propyl paraben, sorbitol solution70% and apple flavor.


Locations(1)

Faculty of Medicine

Tanta, Gharbia Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06268184


Related Trials